Skip to Content
Merck
  • Requirements for mutant and wild-type prion protein misfolding in vitro.

Requirements for mutant and wild-type prion protein misfolding in vitro.

Biochemistry (2015-01-15)
Geoffrey P Noble, Daniel J Walsh, Michael B Miller, Walker S Jackson, Surachai Supattapone
ABSTRACT

Misfolding of the prion protein (PrP) plays a central role in the pathogenesis of infectious, sporadic, and inherited prion diseases. Here we use a chemically defined prion propagation system to study misfolding of the pathogenic PrP mutant D177N in vitro. This mutation causes PrP to misfold spontaneously in the absence of cofactor molecules in a process dependent on time, temperature, pH, and intermittent sonication. Spontaneously misfolded mutant PrP is able to template its unique conformation onto wild-type PrP substrate in a process that requires a phospholipid activity distinct from that required for the propagation of infectious prions. Similar results were obtained with a second pathogenic PrP mutant, E199K, but not with the polymorphic substitution M128V. Moreover, wild-type PrP inhibits mutant PrP misfolding in a dose-dependent manner, and cofactor molecules can antagonize this effect. These studies suggest that interactions between mutant PrP, wild-type PrP, and other cellular factors may control the rate of PrP misfolding in inherited prion diseases.

MATERIALS
Product Number
Brand
Product Description

Avanti
Brain PC, Avanti Polar Lipids 840053C
Avanti
Brain PC, Avanti Polar Lipids 840053P, powder
Avanti
C18(Plasm)-18:1 PE, Avanti Polar Lipids
Avanti
C18(Plasm)-18:1 PE, 1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphoethanolamine, powder